Industry News
Allied finds CardioCel better at seeding stem cells
Tests of tissue engineered by Allied Healthcare’s (ASX:AHZ) ADAPT technology support its ability to be used for a “truly regenerative treatment”, according to its CEO. [ + ]
Cynata’s stem cells show promise in treating critical limb ischemia
An animal trial has shown Cynata’s mesenchymoangioblasts (MCA) cells can help improve blood flow in mice with induced critical limb ischemia. [ + ]
Metabolic eyes human trials for experimental osteoarthritis treatment
A positive result from an animal trial of Calzada (ASX:CZD) subsidiary Metabolic Pharmaceuticals’ osteoarthritis treatment could lead to phase II human trials beginning soon. [ + ]
Anti-ageing protein linked to pancreatic cancer
Sirtuin, which is known for its link to ageing, has been associated with pancreatic cancer, raising the prospect of new treatments. [ + ]
Academy welcomes new Science Minister
The Australian Academy of Science today welcomed the appointment of Chris Bowen as the new Minister for Science and Research. [ + ]
Quantum microscope for living biology
A team of Australian scientists has developed a powerful microscope using the laws of quantum mechanics to probe the inner workings of living cells. [ + ]
New leader for Australia’s astronomy and space science research
CSIRO’s astronomy, spacecraft tracking and space science activities will be headed up by a new leader, with the announcement that Dr Lewis Ball has been appointed as the incoming chief for CSIRO’s Astronomy and Space Science (CASS) division. [ + ]
Discovery in synthetic biology takes us a step closer to new industrial revolution
Scientists report that they have developed a method that cuts down the time it takes to make new ‘parts’ for microscopic biological factories from two days to only six hours. [ + ]
PolyNovo to file with FDA to seek NovoSorb in US
Calzada (ASX:CZD) subsidiary PolyNovo will seek marketing approval in the US for NovoSorb, its dressing for hard-to-heal pressure sores. [ + ]
BioDiem expanding indications for BDM-I
BioDiem (ASX:BDM) is extending a research agreement with US-based NIAID to cover the evaluation of antimicrobial BDM-I in tuberculosis and serious fungal infections. [ + ]
Alchemia progresses with colorectal cancer trial
Alchemia (ASX:ACL) has enrolled the 390th patient for its phase III trial of HA-Irinotecan in metastatic colorectal cancer and expects to reach the primary endpoint in early 2014. [ + ]
Science Academy welcomes commitment to protect Australia’s medical research
The Australian Academy of Science has welcomed a commitment by Tony Abbott and Peter Dutton to protect the nation’s health and medical research budget. [ + ]
One-step test for mitochondrial diseases
More powerful gene-sequencing tools have increasingly been uncovering disease secrets in DNA within the cell nucleus. Now a research team is expanding those rapid next-generation sequencing tests to analyse the DNA that is within the genes inside mitochondria. [ + ]
AusBiotech Business Development Forum 2013
Registration is now open for the 2013 AusBiotech Business Development Workshop and Forum, which will be held in Adelaide from 20-21 March. [ + ]
Plexon celebrates 30 years in neuroscience research, record sales and a new website
Plexon, a leader in hardware and software solutions for neuroscience and behavioural research, has marked 30 years of innovation on the heels of closing its strongest year. [ + ]
